Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Tranexamic Acid in Reducing Hematoma and Seroma Formation in Reconstructive Post-oncologic Breast Surgery

NCT05807074 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT05807074
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05807074 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Tranexamic Acid in Reducing Hematoma and Seroma Formation in Reconstructive Post-oncologic Breast Surgery
Lead sponsor
University of California, San Francisco
Phase
Phase 4
Overall status
Terminated
Start date
April 20, 2023
Completion date
November 30, 2024
Enrollment
23 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer